Fig. 3. Comparison of clinical outcomes between DSM-RFA and SSM-RFA groups.
Patients who initially achieved treatment success and effectiveness were observed for LTP, intrahepatic distant recurrence, and extrahepatic metastasis.
(A) LTP rates of HCC nodules. (B) LTP-free survival and (C) RFS in patients treated using DSM-RFA or SSM-RFA. LTP = local tumor progression, RFS = recurrence-free survival